Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
11 2020
Historique:
received: 23 03 2020
revised: 25 06 2020
accepted: 25 06 2020
pubmed: 19 8 2020
medline: 28 9 2021
entrez: 19 8 2020
Statut: ppublish

Résumé

Microstructural alterations as assessed by diffusion tensor imaging (DTI) are key findings in both Alzheimer's disease (AD) and small vessel disease (SVD). We determined the contribution of each of these conditions to diffusion alterations. We studied six samples (N = 365 participants) covering the spectrum of AD and SVD, including genetically defined samples. We calculated diffusion measures from DTI and free water imaging. Simple linear, multivariable random forest, and voxel-based regressions were used to evaluate associations between AD biomarkers (amyloid beta, tau), SVD imaging markers, and diffusion measures. SVD markers were strongly associated with diffusion measures and showed a higher contribution than AD biomarkers in multivariable analysis across all memory clinic samples. Voxel-wise analyses between tau and diffusion measures were not significant. In memory clinic patients, the effect of SVD on diffusion alterations largely exceeds the effect of AD, supporting the value of diffusion measures as markers of SVD.

Identifiants

pubmed: 32808747
doi: 10.1002/alz.12150
pmc: PMC8102202
mid: NIHMS1697447
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1504-1514

Subventions

Organisme : Austrian Science Fund FWF
ID : I 2889
Pays : Austria
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG024904
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG032438
Pays : United States

Informations de copyright

© 2020 the Alzheimer's Association.

Références

Lancet. 2015 Oct 24;386(10004):1698-706
pubmed: 26595643
Alzheimers Dement (Amst). 2017 Jan 23;6:143-151
pubmed: 28239639
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Alzheimers Res Ther. 2013 Oct 17;5(5):48
pubmed: 24131566
Acta Neuropathol Commun. 2015 Sep 30;3:60
pubmed: 26419828
Neuroimage Clin. 2018 Jun 19;19:963-969
pubmed: 30003033
Mol Psychiatry. 2021 Feb;26(2):614-628
pubmed: 30899092
Neuroimage. 2017 Aug 1;156:423-434
pubmed: 28412443
Ann Neurol. 2016 Aug;80(2):247-58
pubmed: 27323247
JAMA Neurol. 2015 Mar;72(3):316-24
pubmed: 25580592
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
J Alzheimers Dis. 2015;50(3):873-86
pubmed: 26836182
Magn Reson Med. 2009 Sep;62(3):717-30
pubmed: 19623619
Brain Imaging Behav. 2019 Feb;13(1):41-52
pubmed: 28600739
Neuroscience. 2014 Sep 12;276:206-15
pubmed: 24583036
BMC Neurol. 2014 Dec 31;14:254
pubmed: 25551191
Acta Neuropathol. 2017 Sep;134(3):459-473
pubmed: 28638989
Brain. 2017 Jul 1;140(7):1829-1850
pubmed: 28334869
Acta Neuropathol Commun. 2016 Jun 13;4(1):58
pubmed: 27296779
Hum Brain Mapp. 2019 May;40(7):2065-2075
pubmed: 30604903
JAMA Neurol. 2018 Aug 1;75(8):999-1007
pubmed: 29799981
Alzheimers Dement. 2019 Jan;15(1):158-167
pubmed: 30642436
JAMA Neurol. 2014 Dec;71(12):1547-54
pubmed: 25347157
Cerebrovasc Dis. 2015;39(3-4):224-31
pubmed: 25823458
Neuroimage Clin. 2014 Feb 19;4:604-14
pubmed: 24936411
Neuroimage. 2019 Aug 15;197:243-254
pubmed: 31051291
Alzheimers Dement. 2018 Jun;14(6):764-774
pubmed: 29406155
J Cereb Blood Flow Metab. 2019 Aug;39(8):1613-1622
pubmed: 29519198
PLoS One. 2017 Mar 14;12(3):e0173982
pubmed: 28291839
Neurology. 2018 Jul 24;91(4):e313-e318
pubmed: 29959265
Neurobiol Aging. 2017 Aug;56:172-179
pubmed: 28552181
Alzheimers Dement. 2020 Apr;16(4):651-661
pubmed: 32147939
Acta Neuropathol. 2017 Aug;134(2):171-186
pubmed: 28488154
BMC Bioinformatics. 2007 Jan 25;8:25
pubmed: 17254353
Stroke. 2018 Jun;49(6):1340-1347
pubmed: 29752348
Neurology. 2014 Sep 30;83(14):1228-34
pubmed: 25165388
Neuroimage. 2016 Nov 1;141:556-572
pubmed: 27393418
Stroke. 2016 Jun;47(6):1679-84
pubmed: 27103015
Alzheimers Dement. 2015 May;11(5):485-493.e2
pubmed: 25035154
Nat Neurosci. 2018 Mar;21(3):424-431
pubmed: 29403032
J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):352-357
pubmed: 29054920
Acta Neuropathol Commun. 2018 Mar 2;6(1):22
pubmed: 29499767
Neuroimage. 2014 Dec;103:323-333
pubmed: 25271843
Brain. 2018 Oct 1;141(10):3065-3080
pubmed: 30239611
Brain. 2016 Sep;139(Pt 9):2516-27
pubmed: 27329772
Alzheimers Res Ther. 2018 Feb 07;10(1):15
pubmed: 29415768
Ann Neurol. 2016 Oct;80(4):581-92
pubmed: 27518166
Brain. 2018 Mar 1;141(3):888-902
pubmed: 29309541

Auteurs

Sofia Finsterwalder (S)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Naomi Vlegels (N)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Benno Gesierich (B)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Miguel Á Araque Caballero (MÁ)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Nick A Weaver (NA)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Nicolai Franzmeier (N)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Marios K Georgakis (MK)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Marek J Konieczny (MJ)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Huiberdina L Koek (HL)

Department of Geriatrics, University Medical Center Utrecht, Utrecht, the Netherlands.

Celeste M Karch (CM)

Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA.

Neill R Graff-Radford (NR)

Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA.

Stephen Salloway (S)

Butler Hospital, Providence, Rhode Island, USA.

Hwamee Oh (H)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Ricardo F Allegri (RF)

Department of Cognitive Neurology, FLENI Institute for Neurological Research, Buenos Aires, Argentina.

Jasmeer P Chhatwal (JP)

Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Frank Jessen (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Psychiatry, University of Cologne, Medical Faculty, Cologne, Germany.

Emrah Düzel (E)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.

Laura Dobisch (L)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.

Coraline Metzger (C)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.
Department of Psychiatry and Psychotherapy, Otto-von-Guericke University, Magdeburg, Germany.

Oliver Peters (O)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Berlin, Germany.

Enise I Incesoy (EI)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Berlin, Germany.

Josef Priller (J)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Berlin, Germany.

Eike J Spruth (EJ)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Berlin, Germany.

Anja Schneider (A)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Klaus Fließbach (K)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Katharina Buerger (K)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Daniel Janowitz (D)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Stefan J Teipel (SJ)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Ingo Kilimann (I)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Christoph Laske (C)

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Martina Buchmann (M)

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Michael T Heneka (MT)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Frederic Brosseron (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Annika Spottke (A)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Neurology, University of Bonn, Bonn, Germany.

Nina Roy (N)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Birgit Ertl-Wagner (B)

Institute of Clinical Radiology, University Hospital, LMU Munich, Munich, Germany.
Department of Medical Imaging, University of Toronto, Toronto, Canada.

Klaus Scheffler (K)

Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.

Sang Won Seo (SW)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.
Department of Clinical Research Design and Evaluation, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.
Center for Imaging of Neurodegenerative Diseases, University of California, San Francisco, California, USA.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.

Yeshin Kim (Y)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.
Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, South Korea.

Duk L Na (DL)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.
Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.

Hee Jin Kim (HJ)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.

Hyemin Jang (H)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.

Michael Ewers (M)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Johannes Levin (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Department of Neurology, University Hospital, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Reinhold Schmidt (R)

Department of Neurology, Medical University of Graz, Graz, Austria.

Ofer Pasternak (O)

Department of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Martin Dichgans (M)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Geert Jan Biessels (GJ)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Marco Duering (M)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH